Raymond James Financial’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$498K Buy
124,496
+16,379
+15% +$65.5K ﹤0.01% 3987
2025
Q1
$344K Sell
108,117
-872
-0.8% -$2.77K ﹤0.01% 4105
2024
Q4
$583K Buy
+108,989
New +$583K ﹤0.01% 3787